The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
AMD3100 Is a CXCR7 Ligand with Allosteric Agonist Properties
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
The Chemokine SDF-1/CXCL12 Binds to and Signals through the Orphan Receptor RDC1 in T Lymphocytes
Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y. C., Harriague, J., Moepps, B., Arenzana-Seisdedos, F., Thelen, M., & Bachelerie, F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508234200 · Cited by 1,040
Allosteric Modulation of G Protein–Coupled Receptors
May, L. T., Leach, K., Sexton, P. M., & Christopoulos, A. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105159 · Cited by 695
Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690
Roles of G‐protein‐coupled receptor dimerization: From ontogeny to signalling regulation
Terrillon, S., & Bouvier, M. (2004) · EMBO reports · doi:10.1038/sj.embor.7400052 · Cited by 683
Mercier, J.-F., Salahpour, A., Angers, S., Breit, A., & Bouvier, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205767200 · Cited by 473
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03143-5 · Cited by 448
The pleiotropic effects of the SDF-1–CXCR4 axis in organogenesis, regeneration and tumorigenesis
Ratajczak, M. Z., Zuba-Surma, E., Kucia, M., Reca, R., Wojakowski, W., & Ratajczak, J. (2006) · Leukemia · doi:10.1038/sj.leu.2404357 · Cited by 424
Hendrix, C. W., Collier, A. C., Lederman, M. M., Schols, D., Pollard, R. B., Brown, S., Jackson, J. B., Coombs, R. W., Glesby, M. J., Flexner, C. W., et al. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000137371.80695.ef · Cited by 366
New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism
Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317
Chemokines in neoplastic progression
Zlotnik, A. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.004 · Cited by 266
Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M., & Heveker, N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411151200 · Cited by 261
Self-citationGerlach, L. O., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010429200 · Cited by 260
Zhang, W.-B., Navenot, J.-M., Haribabu, B., Tamamura, H., Hiramatu, K., Omagari, A., Pei, G., Manfredi, J. P., Fujii, N., Broach, J. R., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200889200 · Cited by 247
CXCR7, CXCR4 and CXCL12: An eccentric trio?
Thelen, M., & Thelen, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.04.020 · Cited by 245
Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor
Rosenkilde, M. M., Gerlach, L.-O., Jakobsen, J. S., Skerlj, R. T., Bridger, G. J., & Schwartz, T. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309546200 · Cited by 239
Brelot, A., Heveker, N., Montes, M., & Alizon, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000776200 · Cited by 236
Self-citationLigand-independent Dimerization of CXCR4, a Principal HIV-1 Coreceptor
Babcock, G. J., Farzan, M., & Sodroski, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210140200 · Cited by 221
Fricker, S. P., Anastassov, V., Cox, J., Darkes, M. C., Grujic, O., Idzan, S. R., Labrecque, J., Lau, G., Mosi, R. M., Nelson, K. L., et al. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.010 · Cited by 215
Ayoub, M. A., Levoye, A., Delagrange, P., & Jockers, R. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000398 · Cited by 207
Hamdan, F. F., Audet, M., Garneau, P., Pelletier, J., & Bouvier, M. (2005) · SLAS Discovery · doi:10.1177/1087057105275344 · Cited by 183 · cited 2×
“To quantitatively measure arrestin recruitment, we used a previously described (Hamdan et al., 2005) BRET-based system.”
MethodDetermining the Potency and Molecular Mechanism of Action of Insurmountable Antagonists
Kenakin, T., Jenkinson, S., & Watson, C. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.107375 · Cited by 174
Analysis of Allosterism in Functional Assays
Ehlert, F. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.090886 · Cited by 168
Antigenically Distinct Conformations of CXCR4
Baribaud, F., Edwards, T. G., Sharron, M. P., Brelot, A., Heveker, N., Price, K., Mortari, F., Alizon, M., Tsang, M., & Doms, R. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.8957-8967.2001 · Cited by 159
Self-citationCabıoğlu, N., Summy, J. M., Miller, C. P., Parikh, N. U., Şahin, A. A., Tuzlalı, S., Pumiglia, K. M., Gallick, G. E., & Price, J. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1303 · Cited by 157
Labrosse, B., Brelot, A., Heveker, N., Sol‐Foulon, N., Schols, D., Clercq, E. D., & Alizon, M. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6381-6388.1998 · Cited by 142
Self-citationMetal Ion Enhanced Binding of AMD3100 to Asp262 in the CXCR4 Receptor
Gerlach, L. O., Jakobsen, J. S., Kepp, K. P., ROSENKILDE, M. M., Skerlj, R. T., Ryde, U., Bridger, G. J., & Schwartz, T. W. (2002) · Biochemistry · doi:10.1021/bi0264770 · Cited by 140
Zhou, N., Luo, Z., Luo, J., Liu, D., Hall, J. W., Pomerantz, R. J., & Huang, Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106582200 · Cited by 135
BRET analysis of GPCR oligomerization: newer does not mean better
Bouvier, M., Heveker, N., Jockers, R., Marullo, S., & Milligan, G. (2006) · Nature Methods · doi:10.1038/nmeth0107-3 · Cited by 128
Self-citationPotential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100
Clercq, E. D. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054867075 · Cited by 89
Ago-Allosteric Modulation and Other Types of Allostery in Dimeric 7TM Receptors
Schwartz, T. W., & Holst, B. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600567570 · Cited by 85
Gupta, S. K., Pillarisetti, K., Thomas, R. A., & Aiyar, N. V. (2001) · Immunology Letters · doi:10.1016/s0165-2478(01)00228-0 · Cited by 83
Jensen, P. C., Thiele, S., Ulven, T., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803458200 · Cited by 44
Cited by
CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression
Sun, X., Cheng, G., Hao, M., Zheng, J., Zhou, X., Zhang, J., Taichman, R. S., Pienta, K. J., & Wang, J. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9256-x · Cited by 727
β-arrestin- but not G protein-mediated signaling by the “decoy” receptor CXCR7
Rajagopal, S., Kim, J., Ahn, S., Craig, S., Lam, C. M., Gerard, N. P., Gerard, C., & Lefkowitz, R. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912852107 · Cited by 600
CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
Naumann, U., Cameroni, E., Pruenster, M., Mahabaleshwar, H., Raz, E., Zerwes, H.-G., Rot, A., & Thelen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009175 · Cited by 470
Immune regulation by atypical chemokine receptors
Nibbs, R. J. B., & Graham, G. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3544 · Cited by 407
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
Duda, D. G., Kozin, S. V., Kirkpatrick, N. D., Xu, L., Fukumura, D., & Jain, R. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2636 · Cited by 395
Metadata
- Authors
- Kalatskaya, I., Berchiche, Y. A., Gravel, S., Limberg, B. J., Rosenbaum, J. S., & Heveker, N.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 75
- Issue
- 5
- Pages
- 1240-1247
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2120067620
- Cited by
- 309
- References
- 35
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.